Inventor · disambiguated record
Gijsbertus Franciscus Maria Verheijden
Also filed as: VERHEIJDEN GIJSBERTUS FRANCISC · VERHEIJDEN GIJSBERTUS FRANCISCUS MARIA
10 granted patents·2 pending applications·85 citations·filing 1995–2022
86Inventor score
Top patents by PatentIndex Score
12 records- 0191US9421278B2Duocarmycin ADCS showing improved in vivo antitumor activitySYNTHON BIOPHARMACEUTICALS BV·Filed 2015·Granted Aug 23, 2016·14 cites·10 claims
- 0272US11382982B2Duocarmycin ADCs showing improved in vivo antitumor activityBYONDIS BV·Filed 2019·Granted Jul 12, 2022·0 cites·10 claims
- 0371US11274159B2Anti-SIRPα antibodiesBYONDIS BV·Filed 2018·Granted Mar 15, 2022·1 cites·10 claims
- 0471US5843449AProteins and novel peptides derived from autoantigen for use in immunotherapy of autoimmune diseasesAKZO NOBEL NV·Filed 1996·Granted Dec 1, 1998·36 cites·8 claims
- 0566US10603387B2Duocarmycin ADCs showing improved in vivo antitumor activitySYNTHON BIOPHARMACEUTICALS BV·Filed 2017·Granted Mar 31, 2020·0 cites·13 claims
- 0663US5736507APeptides derived from autoantigen for use in immunotherapy of autoimmue diseasesAKZO NOBEL NV·Filed 1995·Granted Apr 7, 1998·22 cites·10 claims
- 0761US11718681B2Anti-SIRP α antibodiesBYONDIS BV·Filed 2022·Granted Aug 8, 2023·0 cites·23 claims
- 0858US12180295B2Humanized anti-SIRPα antibodiesBYONDIS BV·Filed 2019·Granted Dec 31, 2024·0 cites·22 claims
- 0953US6184204B1Peptides suitable for use in antigen specific immunosuppressive therapyAKZO NOBEL NV·Filed 1997·Granted Feb 6, 2001·12 cites·2 claims
- 1052US2017014525A1Duocarmycin adcs showing improved in vivo antitumor activitySYNTHON BIOPHARMACEUTICALS BV·Filed 2016·Application pending·0 cites
- 1144US2002177554A1Novel peptides for use in treatment of T-cell mediated cartilage destruction in autoimmune diseasesAKZO NOBEL NV·Filed 2001·Application pending·0 cites
- 1229US6964766B1Peptides for use in immunotherapy of autoimmune diseasesAKZO NOBEL NV·Filed 1999·Granted Nov 15, 2005·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Gijsbertus Franciscus Maria Verheijden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →